Concentrix (NASDAQ:CNXC) Upgraded at Wall Street Zen

Concentrix (NASDAQ:CNXC) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

A number of other analysts have also recently weighed in on the company. Robert W. Baird set a $52.00 price target on Concentrix in a research note on Wednesday, January 14th. Barrington Research reiterated an “outperform” rating and issued a $62.00 price objective on shares of Concentrix in a report on Monday, January 12th. Finally, Weiss Ratings cut Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Concentrix currently has an average rating of “Hold” and a consensus price target of $63.75.

Concentrix Stock Up 0.5%

Shares of Concentrix stock opened at $30.39 on Friday. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.67. Concentrix has a 52-week low of $29.35 and a 52-week high of $66.00. The company has a market capitalization of $1.87 billion, a P/E ratio of -1.46, a P/E/G ratio of 0.32 and a beta of 0.50. The company has a 50 day moving average of $40.16 and a 200 day moving average of $43.83.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings data on Tuesday, January 13th. The company reported $2.95 EPS for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. The company had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, research analysts forecast that Concentrix will post 10.11 EPS for the current fiscal year.

Insider Buying and Selling

In other Concentrix news, CEO Christopher A. Caldwell purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 29th. The stock was purchased at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the purchase, the chief executive officer directly owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Concentrix

Institutional investors and hedge funds have recently made changes to their positions in the business. Huntington National Bank increased its position in Concentrix by 6,011.1% in the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock valued at $25,000 after acquiring an additional 541 shares during the period. Quent Capital LLC acquired a new stake in Concentrix during the 3rd quarter worth approximately $29,000. Larson Financial Group LLC grew its stake in shares of Concentrix by 224.9% in the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after purchasing an additional 479 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the last quarter. Finally, Rothschild Investment LLC grew its position in Concentrix by 14,980.0% in the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock valued at $35,000 after buying an additional 749 shares during the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.